Navigation Links
FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
Date:2/6/2008

ATLANTA, Feb. 6 /PRNewswire/ -- UCB today announced that the U.S. Food and Drug Administration (FDA) agreed to accept, for filing and review, a biologics license application (BLA) for Cimzia(R) (certolizumab pegol) for the treatment of adult patients with active rheumatoid arthritis (RA). Cimzia(R) is an investigational agent. If approved, Cimzia(R) will be the first and only PEGylated anti-TNF (Tumor Necrosis Factor) biologic therapy available for the treatment of rheumatoid arthritis.

"As a new anti-TNF, we believe that Cimzia(R) would provide an important new option for people living with this disease," said Olav Hellebo, President Inflammation Operations, UCB.

The BLA is based on data from more than 2,367 patients and includes three multi-center, placebo-controlled Phase III trials which were recently presented at the American College of Rheumatology (ACR) Annual Scientific Meeting.

In these studies, Cimzia(R), given with methotrexate, was shown to be significantly more effective than methotrexate alone for the inhibition of joint damage progression in patients with active RA as early as 24 weeks (RAPID 1 and RAPID 2). Cimzia(R) was shown to rapidly reduce the signs and symptoms of active RA with peak ACR50 and 70 responses achieved at 14 and 16 weeks. Improvement in physical function and quality of life measures were also seen for up to one year (RAPID 1). Further, Cimzia(R) administered as monotherapy showed significant improvement in signs and symptoms of RA from week 1, and this benefit was maintained through week 24 (Study 011). The most commonly occurring adverse reactions were headache, nasopharyngitis, and upper respiratory tract infections. Reported serious adverse reactions were infections (including tuberculosis) and malignancies (including lymphoma), consistent with findings from other trials in the anti-TNF class.

Preparation for submission of a Marketing Authorization Application (MAA) to the European Medicines Ag
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
2. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
5. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
6. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
7. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
8. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
9. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
10. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
11. AEterna Zentaris Announces Outcome of Managements Strategic Review

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...at Economic Club of Canada , ...mbassador to Speak at Economic Club of Canada., , ...ernational Investment, and Chairman and CEO of the...avid Appia go to www.investinfrance.org . , , ,W...ress to discuss recent pro-business initiatives ad...
(Date:11/25/2009)...-ArdeaBiosciences,Inc.(Nasdaq: RDEA )announcedtoda...iveofficer,willpresentatthePiperJaffray21stAnnualH...ollows:,PiperJaffray21stAnnualHealthCareConferenc...Time,Location:TheNewYorkPalaceHotel,NewYork,NY,Web...arget=,_blank,title=,http://www.corporate-ir.net/i...
(Date:11/24/2009)...womoreprestigiousuniversitieshavejoinedBioCareerCe...eforlifescienceprofessionals. ,, Northwesternan...ing28othermajorlifesciencetrainingInstitutions. ,...rpost-graduatesinthelifesciences.Whiletherearehund...rCenteristheonlyonethatserveslifesciencepost-gradu...
(Date:11/24/2009)...e-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN )t...nsbytheU.S.BankruptcyCourtfortheDistrictofDelaware...arypetitionfor,reliefunderChapter11oftheUnitedStat...eordersissuedbytheBankruptcyCourtallowthecompanyto...ceedings.Inparticular,the,companyreceivedinterimBa...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...- William R. Hendee will retire effective June 30 ...ces at the Medical College of Wisconsin , and dev...nal. , ,Hendee, who also will retire as president ...rement on June 19. While the Medical College condu... is likely to look inside the organization for int...
...e to the Wisconsin State Senate five years ago, ... done little to transform its economy from an old ...el favoring innovation and ideas. , ,Simply put, t... at the expense of creating new ones. The lack of ...f the line when it came to capital formation and j...
...mpanies that ranked among the best places to work ...eld are ranked highly because they offer employee ... job satisfaction. , , Northwestern Mutual Life I...ce Group , Madison, and Schneider National Inc. ,...f America,s top 100 companies complied by Compute...
Other Biology Technology:Medical College grad school dean Bill Hendee to retire 2It's time for Wisconsin's economy to grow 2It's time for Wisconsin's economy to grow 3Wisconsin companies among Best IT Workplaces 2
(Date:11/24/2009)...rican College of Medical Toxicology (ACMT) have si...n of the Journal of Medical Toxicology (JMT), th... 2010. It was previously published by the Univers...dical Toxicology , an international, peer-reviewed...d practice of medical toxicology. The quarterly j...
(Date:11/24/2009)...mber 24, 2009) New research on bacterial communit...eveals predictable temporal patterns, suggesting t...ers for monitoring climate change in the polar reg...edings of the National Academy of Sciences Early ...ix rivers shifted synchronously over time, correla...
(Date:11/23/2009)... November 23, 2009 Applied mathematicians dissec...ncifolia ), a characteristic long leaf with a sadd...along the edges. The simple cause of the lily,s fa...ing during differential growthwas revealed by usin...bons. , Haiyi Liang, a postdoctoral student at H...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Beazley Expands Healthcare Team with Appointment of Tom McNally 49634 1Beazley Expands Healthcare Team with Appointment of Tom McNally 49634 2Seroquels First and Second Line Patient Share Has Grown Since Last Years Analysis of Prescribing Trends in Bipolar Disorder 49629 1Seroquels First and Second Line Patient Share Has Grown Since Last Years Analysis of Prescribing Trends in Bipolar Disorder 49629 2Seroquels First and Second Line Patient Share Has Grown Since Last Years Analysis of Prescribing Trends in Bipolar Disorder 49629 3Unspoken memories of Holocaust survivors find silent and nonpathological expression 49625 1Unspoken memories of Holocaust survivors find silent and nonpathological expression 49625 2
..., R.I. [Brown University] Brown University, with ...and, has been awarded a $12-million, five-year con...Children,s Study, a groundbreaking research projec... Institute of Child Health and Human Development (...e National Institutes of Health, announced the awa...
...very that counters prevailing thought, a study in ...es involved in "fat-burning" can actually increase...esity. These unusual findings, appearing this week...ght-loss therapy. , Humans and other warm-bloode...to maintain body temperature, and it,s currently b...
... are known as a keystone species, filling such an ...them, entire ecosystems can collapse. Scientists a... farther-reaching effects that extend to terrestri...op predator: the bald eagle. , In nearshore mari... 250 feet and function much like trees in a forest...
Other Biology News:Brown University and Women & Infants Hospital expand national children's study to Bristol County 2Brown University and Women & Infants Hospital expand national children's study to Bristol County 3Brown University and Women & Infants Hospital expand national children's study to Bristol County 4Making metabolism more inefficient can reduce obesity 2Decline in Alaskan sea otters affects bald eagles' diet 2Decline in Alaskan sea otters affects bald eagles' diet 3
...-HODE-d4 contains 4 deuterium atoms at the 9, 10, ... internal standard for the quantification of 9(S)-...produced by the lipoxygenation of linoleic acid in...atherosclerotic plaques, as an esterified componen...
12(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
Silencer Pre-designed siRNA, HPLC purified from Ambion
Biology Products: